Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel De Backer

Showing results (61-70 of 358) with videos related to

Pageof 36
Sort By:
Hospital Practice (1995)|September 30, 2010
Microcirculatory alterations in the critically illJean-Louis Vincent, Daniel De Backer
Critical Care Medicine|June 20, 2002
Norepinephrine administration in septic shock: how much is enough?Daniel De Backer, Jean-Louis Vincent
Critical Care (London, England)|August 12, 2016
Saline versus balanced solutions: are clinical trials comparing two crystalloid solutions really needed?Jean-Louis Vincent, Daniel De Backer
Critical Care (London, England)|March 6, 2003
The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is dopamine rather than norepinephrineJean-Louis Vincent, Daniel de Backer,
Critical Care Medicine|April 9, 2005
Decreased mortality with the use of the pulmonary artery catheter?Daniel De Backer, Jean-Louis Vincent
Critical Care Medicine|December 26, 2007
Novel insights into the effects of inducible nitric oxide synthase inhibition during sepsisJean-Charles Preiser, Daniel De Backer
Intensive Care Medicine|March 9, 2016
Early goal-directed therapy: do we have a definitive answer?Daniel De Backer, Jean-Louis Vincent
Intensive Care Medicine|January 26, 2019
Clinical examination: a trigger but not a substitute for hemodynamic evaluationDaniel De Backer, Antoine Vieillard-Baron
American Journal of Respiratory and Critical Care Medicine|June 18, 2019
Understanding Hyperlactatemia in Human Sepsis: Are We Making Progress?Daniel De Backer, Jean-Louis Vincent
Current Opinion in Anaesthesiology|April 25, 2009
Link between coagulation abnormalities and microcirculatory dysfunction in critically ill patientsDaniel De Backer, Katia Donadello, Raphaël Favory
Pageof 36

Showing results (61-70 of 358) with videos related to

Sort By:
Pageof 36
Hospital Practice (1995)|September 30, 2010
Microcirculatory alterations in the critically illJean-Louis Vincent, Daniel De Backer
Critical Care Medicine|June 20, 2002
Norepinephrine administration in septic shock: how much is enough?Daniel De Backer, Jean-Louis Vincent
Critical Care (London, England)|August 12, 2016
Saline versus balanced solutions: are clinical trials comparing two crystalloid solutions really needed?Jean-Louis Vincent, Daniel De Backer
Critical Care (London, England)|March 6, 2003
The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is dopamine rather than norepinephrineJean-Louis Vincent, Daniel de Backer,
Critical Care Medicine|April 9, 2005
Decreased mortality with the use of the pulmonary artery catheter?Daniel De Backer, Jean-Louis Vincent
Critical Care Medicine|December 26, 2007
Novel insights into the effects of inducible nitric oxide synthase inhibition during sepsisJean-Charles Preiser, Daniel De Backer
Intensive Care Medicine|March 9, 2016
Early goal-directed therapy: do we have a definitive answer?Daniel De Backer, Jean-Louis Vincent
Intensive Care Medicine|January 26, 2019
Clinical examination: a trigger but not a substitute for hemodynamic evaluationDaniel De Backer, Antoine Vieillard-Baron
American Journal of Respiratory and Critical Care Medicine|June 18, 2019
Understanding Hyperlactatemia in Human Sepsis: Are We Making Progress?Daniel De Backer, Jean-Louis Vincent
Current Opinion in Anaesthesiology|April 25, 2009
Link between coagulation abnormalities and microcirculatory dysfunction in critically ill patientsDaniel De Backer, Katia Donadello, Raphaël Favory
Pageof 36